دورية أكاديمية
SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes.
| العنوان: | SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes. |
|---|---|
| المؤلفون: | Baldelli L; Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA., Marjot T; Oxford Liver Unit, Translational Gastroenterology Unit, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK., Barnes E; Oxford Liver Unit, Translational Gastroenterology Unit, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK., Barritt AS; Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA., Webb GJ; Cambridge Liver Unit, Addenbrooke's Hospital, Cambridge, UK., Moon AM; Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA. |
| المصدر: | Gut and liver [Gut Liver] 2023 Jan 15; Vol. 17 (1), pp. 12-23. Date of Electronic Publication: 2022 Dec 02. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Editorial Office of Gut and Liver Country of Publication: Korea (South) NLM ID: 101316452 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-1212 (Electronic) Linking ISSN: 19762283 NLM ISO Abbreviation: Gut Liver Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Seoul : Editorial Office of Gut and Liver |
| مواضيع طبية MeSH: | COVID-19*/complications , Liver Diseases*/complications , Liver Diseases*/epidemiology, Humans ; SARS-CoV-2 ; Pandemics |
| مستخلص: | The impact of the coronavirus disease 2019 (COVID-19) pandemic has been immense, and it continues to have lasting repercussions. While the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus primarily infects the respiratory system, other organ systems are affected, including the liver. Scientific knowledge on the role of SARS-CoV-2 infection and liver injury has evolved rapidly, with recent data suggesting specific hepatotropism of SARS-CoV-2. Moreover, additional concerns have been raised in regard to long-term liver damage, related to emerging cases of post-COVID-19 cholangiopathy and chronic cholestasis. Great effort has also been focused on studying how specific subpopulations with chronic medical conditions might be disproportionately impacted by COVID-19. One such population includes individuals with chronic liver disease (CLD) and cirrhosis, with an expanding body of research indicating these patients being particularly susceptible to adverse outcomes. In this review, we provide an updated summary on the current pathogenesis and mechanism of liver injury in the setting of SARS-CoV-2 infection, the association between health outcomes and SARS-CoV-2 infection in patients with CLD, and the unique consequences of the COVID-19 pandemic on the routine care of patients with CLD. |
| References: | Clin Gastroenterol Hepatol. 2022 May;20(5):e1217-e1218. (PMID: 34311112) JAMA. 2020 Mar 17;323(11):1061-1069. (PMID: 32031570) J Hepatol. 2020 Sep;73(3):705-708. (PMID: 32446714) JMIR Public Health Surveill. 2021 Nov 26;7(11):e31635. (PMID: 34653017) Lancet Gastroenterol Hepatol. 2021 Mar;6(3):156-158. (PMID: 33444545) Alcohol Res. 2015;37(2):159-70. (PMID: 26695755) JAMA. 2020 Aug 25;324(8):782-793. (PMID: 32648899) Hepatology. 2021 Jul;74(1):296-311. (PMID: 33219516) JHEP Rep. 2021 Jun;3(3):100260. (PMID: 33644725) Clin Mol Hepatol. 2020 Jul;26(3):243-250. (PMID: 32570302) J Hepatol. 2020 Aug;73(2):451-453. (PMID: 32278005) J Hepatol. 2020 Oct;73(4):807-816. (PMID: 32437830) Lancet Respir Med. 2020 Apr;8(4):420-422. (PMID: 32085846) Clin Gastroenterol Hepatol. 2022 Jul;20(7):1553-1560.e78. (PMID: 35124268) Mod Pathol. 2020 Nov;33(11):2147-2155. (PMID: 32792598) Clin Mol Hepatol. 2021 Oct;27(4):515-523. (PMID: 34530524) Gastroenterology. 2021 May;160(6):2162-2164.e3. (PMID: 33434604) J Hepatol. 2022 Jul;77(1):250-251. (PMID: 35282896) Hepatology. 2021 Oct;74(4):1750-1765. (PMID: 33961298) Gastroenterology. 2021 Nov;161(5):1487-1501.e5. (PMID: 34284037) Liver Int. 2020 Sep;40(9):2095-2103. (PMID: 32239796) J Hepatol. 2019 Jan;70(1):151-171. (PMID: 30266282) J Hepatol. 2021 Mar;74(3):567-577. (PMID: 33035628) J Hepatol. 2020 Oct;73(4):995-996. (PMID: 32502510) Dig Dis Sci. 2021 Jun;66(6):1767-1769. (PMID: 32875529) Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076) Dig Dis Sci. 2022 Jan;67(1):93-99. (PMID: 33507442) Nat Metab. 2022 Mar;4(3):301-302. (PMID: 35347317) Am J Gastroenterol. 2022 Apr 1;117(4):678-684. (PMID: 35029156) JAMA. 2020 May 26;323(20):2052-2059. (PMID: 32320003) J Hepatol. 2021 Jun;74(6):1335-1343. (PMID: 33508378) J Hepatol. 2022 Mar;76(3):740-742. (PMID: 34813919) Clin Transl Gastroenterol. 2021 Jun 1;12(6):e00365. (PMID: 34060496) J Hepatol. 2020 Sep;73(3):719-721. (PMID: 32348790) Liver Int. 2018 Feb;38 Suppl 1:126-133. (PMID: 29427501) Drug Saf. 2020 Jul;43(7):615-617. (PMID: 32514859) Hepatology. 2020 Aug;72(2):389-398. (PMID: 32359177) Am J Gastroenterol. 2021 Jul 1;116(7):1414-1425. (PMID: 33993134) JAMA Intern Med. 2021 Oct 1;181(10):1306-1314. (PMID: 34254978) J Hepatol. 2020 Nov;73(5):1231-1240. (PMID: 32553666) Tech Innov Gastrointest Endosc. 2021;23(4):313-321. (PMID: 34345871) Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266. (PMID: 31981519) Clin Gastroenterol Hepatol. 2021 Jul;19(7):1469-1479.e19. (PMID: 32950749) J Hepatol. 2019 Apr;70(4):797-799. (PMID: 30635243) Chest. 2018 Jul;154(1):58-68. (PMID: 29288645) Aliment Pharmacol Ther. 2017 Dec;46(11-12):1070-1076. (PMID: 29023905) Ann Hepatol. 2021 Jan-Feb;20:100271. (PMID: 33099028) Am J Epidemiol. 2006 Aug 1;164(3):263-71. (PMID: 16775042) Liver Int. 2020 Sep;40(9):2110-2116. (PMID: 32654359) JAMA. 1996 Jan 3;275(1):50-4. (PMID: 8531287) World J Gastroenterol. 2020 Dec 28;26(48):7693-7706. (PMID: 33505145) Gut Liver. 2021 Jul 15;15(4):606-615. (PMID: 33782216) Hepatol Int. 2022 Jun;16(3):691-701. (PMID: 35403977) Hepatology. 2020 Oct;72(4):1169-1176. (PMID: 32725890) Liver Int. 2021 Oct;41(10):2404-2417. (PMID: 34018314) Nat Metab. 2022 Mar;4(3):310-319. (PMID: 35347318) Liver Int. 2021 Jan;41(1):20-32. (PMID: 33190346) Korean J Intern Med. 2021 Sep;36(5):1092-1101. (PMID: 34399573) BMJ Case Rep. 2020 Nov 9;13(11):. (PMID: 33168538) Nature. 2020 Aug;584(7821):430-436. (PMID: 32640463) J Hepatocell Carcinoma. 2021 Sep 23;8:1159-1167. (PMID: 34589445) Crit Care Med. 2003 Mar;31(3):869-77. (PMID: 12626999) Immunol Rev. 2009 Jan;227(1):75-86. (PMID: 19120477) Biochem Biophys Res Commun. 2020 May 21;526(1):135-140. (PMID: 32199615) Can J Gastroenterol Hepatol. 2021 Oct 5;2021:1622533. (PMID: 34621710) J Hepatol. 2020 Sep;73(3):566-574. (PMID: 32298767) Liver Int. 2020 Aug;40(8):2038-2040. (PMID: 32352224) Lancet Gastroenterol Hepatol. 2020 Jul;5(7):667-678. (PMID: 32405603) Hepatology. 2021 Mar;73(3):890-900. (PMID: 32415860) Gastroenterology. 2020 Oct;159(4):1589-1591.e4. (PMID: 32565015) Liver Int. 2021 Aug;41(8):1824-1831. (PMID: 33534931) Hepatology. 2021 Aug;74(2):1049-1064. (PMID: 33577086) Telemed J E Health. 2022 May;28(5):666-674. (PMID: 34757827) Hepatol Commun. 2021 Sep;5(9):1616-1621. (PMID: 34510833) Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264) Am J Gastroenterol. 2021 May 1;116(5):1077-1082. (PMID: 33464757) Gut. 2021 Apr;70(4):733-742. (PMID: 32641471) Clin Gastroenterol Hepatol. 2022 Sep;20(9):2142-2144.e2. (PMID: 35314353) Egypt Liver J. 2022;12(1):9. (PMID: 35096428) Gut. 2021 Oct;70(10):1925-1932. (PMID: 33514597) J Hepatol. 2022 Sep;77(3):653-659. (PMID: 35461912) J Leukoc Biol. 2009 Nov;86(5):1097-104. (PMID: 19602670) Hepatology. 2022 Dec;76(6):1563-1575. (PMID: 35596929) Hepatology. 2021 Apr;73(4):1509-1520. (PMID: 32602604) Front Med (Lausanne). 2021 Mar 29;8:636637. (PMID: 33855033) Hepatol Commun. 2021 Sep;5(9):1586-1604. (PMID: 34510830) Hepatol Commun. 2022 Apr;6(4):889-897. (PMID: 34708575) Nat Med. 2020 Jul;26(7):1017-1032. (PMID: 32651579) J Hepatol. 2021 Apr;74(4):944-951. (PMID: 33563499) Clin Gastroenterol Hepatol. 2022 Oct;20(10):2405-2408.e3. (PMID: 35716904) Prev Chronic Dis. 2021 Jul 01;18:E66. (PMID: 34197283) Hepatol Commun. 2020 Dec 10;5(2):177-188. (PMID: 33230491) Nat Rev Gastroenterol Hepatol. 2021 May;18(5):348-364. (PMID: 33692570) Clin Infect Dis. 2020 Jan 2;70(2):193-199. (PMID: 30874791) J Hepatol. 2021 Aug;75(2):439-441. (PMID: 33905793) Nat Cancer. 2022 Sep;3(9):1039-1051. (PMID: 35715501) J Clin Endocrinol Metab. 2008 Oct;93(10):3833-8. (PMID: 18628524) Hepatology. 2021 Jul;74(1):322-335. (PMID: 33219546) J Hepatol. 2021 Jan;74(1):31-36. (PMID: 32777322) Vaccines (Basel). 2022 Feb 28;10(3):. (PMID: 35335009) |
| معلومات مُعتمدة: | United Kingdom WT_ Wellcome Trust |
| فهرسة مساهمة: | Keywords: COVID-19; Cirrhosis; Liver; SARS-CoV-2; Tropism |
| تواريخ الأحداث: | Date Created: 20221202 Date Completed: 20230116 Latest Revision: 20230831 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC9840920 |
| DOI: | 10.5009/gnl220327 |
| PMID: | 36457261 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2005-1212 |
|---|---|
| DOI: | 10.5009/gnl220327 |